Definition:
The Cold and Cough market encompasses a range of over-the-counter (OTC) products sold through pharmacies. These products include both natural and synthetic agents designed to alleviate symptoms related to cough, cold, sore throat, expectorants, and flu-like infections. The market includes various forms of medication such as pills, syrups, lozenges, sprays, ointments, and granulates for both external and internal usage. However, the market excludes prescription medicines, products contrary to state regulations, or those not explicitly designed for cold or cough relief, such as painkillers. Some of the leading products in this market include nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, and Isla Moos. This market exclusively covers product sales through pharmacies.
Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Cold & Cough Remedies (Pharmacies) market in Chile is experiencing significant growth and development.
Customer preferences: Consumers in Chile are increasingly seeking over-the-counter remedies for cold and cough symptoms. This shift in consumer behavior can be attributed to several factors. Firstly, the convenience of purchasing these remedies from pharmacies makes them an attractive option for consumers. Additionally, the rising awareness of the importance of self-care and the desire to alleviate symptoms quickly and effectively has also contributed to the increased demand for cold and cough remedies.
Trends in the market: One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Chile is the growing demand for natural and herbal remedies. Consumers are becoming more conscious of the potential side effects of conventional medications and are seeking alternative options. This trend is in line with the global shift towards natural and organic products. As a result, pharmaceutical companies are introducing a wider range of natural remedies to cater to this growing demand. Another trend in the market is the increasing popularity of combination products. These products offer a combination of multiple active ingredients to target various cold and cough symptoms. Consumers find these products convenient and cost-effective as they address multiple symptoms with a single medication. This trend is driven by the desire for simplicity and efficiency in managing cold and cough symptoms.
Local special circumstances: Chile has a high incidence of cold and cough due to its geographical location and climate. The country experiences cold winters, which can lead to an increase in respiratory infections. This local special circumstance creates a consistent demand for cold and cough remedies throughout the year. Additionally, the country's aging population also contributes to the demand for these remedies as older individuals are more susceptible to respiratory illnesses.
Underlying macroeconomic factors: The growing middle class in Chile is a significant driver of the Cold & Cough Remedies (Pharmacies) market. As disposable incomes rise, consumers have more purchasing power to spend on healthcare products. This increase in purchasing power has led to a greater demand for over-the-counter remedies for cold and cough symptoms. Furthermore, the Chilean government's focus on healthcare and improving access to medication has also contributed to the growth of the market. The government has implemented policies to increase the availability of medications in pharmacies, making it easier for consumers to access cold and cough remedies. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Chile is experiencing growth and development due to changing customer preferences, such as the demand for natural and combination products. Local special circumstances, such as the country's climate and aging population, also contribute to the market's growth. Additionally, underlying macroeconomic factors, such as the growing middle class and government initiatives, play a significant role in driving the market's expansion.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.